On October 31, 2017 Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), reported that third quarter 2017 financial results will be released on Tuesday, November 7, 2017 before the market opens (Press release, Cambrex, OCT 31, 2017, View Source [SID1234521350]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company will host a conference call to discuss the financial results.

Third Quarter 2017 Earnings Conference Call

When: Tuesday, November 7, 2017 at 8:30 a.m. Eastern Time

Dial-in:

1-866-548-4713 for U.S.
1-323-794-2093 for International
Passcode: 1511082
Dial-in Replay:

1-888-203-1112 for U.S.
1-719-457-0820 for International
Passcode: 1511082
Available through Tuesday, November 14, 2017
Webcast: www.cambrex.com